Temozolomide and Thalidomide in Treating Patients With Metastatic, Locally Advanced, or Unresectable Leiomyosarcoma

This study is ongoing, but not recruiting participants.

Study NCT00033709 Information provided by National Cancer Institute (NCI)

First Received: April 9, 2002 Last Updated: July 23, 2008 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

About Study Results Reporting on ClinicalTrials.gov

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given

Publications:

Boyar M, Keohan ML, Hesdorffer M, et al.: Phase II study of temozolomide and thalidomide in patients with unresectable or metastatic leiomyosarcoma. [Abstract] J Clin Oncol 23 (Suppl 16): A-9029, 823s, 2005.